G. Grossfeld

发表

Neoadjuvant strategies for prostate cancer prior to radical prostatectomy.

M. Meng, P. Carroll, E. Small, 2002, Seminars in urologic oncology.

Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.

P. Carroll, K. Shinohara, G. Grossfeld, 2001, The Journal of urology.

Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.

P. Carroll, H. Hricak, M. Litwin, 2001, American family physician.

Treatment and outcome of invasive bladder cancer in patients after renal transplantation.

M. Meng, P. Carroll, V. Master, 2004, The Journal of urology.

Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women.

R. Cote, S. Groshen, S. Boyd, 1999, Urology.

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity.

P. Carroll, K. Chew, F. Waldman, 1998, The Journal of urology.

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.

P. Carroll, E. Small, G. Grossfeld, 2001, Urology.

Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients

D. Esrig, J. Freeman, J. Stein, 2009, World Journal of Urology.

The prostatic gland: malignancies other than adenocarcinomas.

G. Grossfeld, S. Varghese, Shaju L. Varghese, 2000, Radiologic clinics of North America.

Surgery for Prostate Cancer: Rationale, Technique and Outcomes

M. Meng, P. Carroll, C. Kane, 2004, Cancer and Metastasis Reviews.

Surgery for prostate cancer: rationale, technique and outcomes.

M. Meng, P. Carroll, C. Kane, 2002 .

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

D. Lubeck, S. Mehta, P. Carroll, 2002, Urology.

Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.

P. Carroll, K. Shinohara, M. Roach, 2000, Urology.

Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.

D. Lubeck, S. Mehta, P. Carroll, 2003, Urology.

A review of measurement of patient preferences for treatment outcomes after prostate cancer.

D. Lubeck, P. Carroll, G. Grossfeld, 2002, Urology.

Fine Needle Aspiration Cytology of Adult Perineal Rhabdomyosarcoma

M. Meng, F. Baehner, G. Grossfeld, 2006, Acta Cytologica.

Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy

D. Lubeck, P. Carroll, G. Grossfeld, 2002 .

National practice patterns and time trends in androgen ablation for localized prostate cancer.

M. Cooperberg, D. Lubeck, P. Carroll, 2003, Journal of the National Cancer Institute.

PCN21: HEALTH-RELATED QUALITY OF LIFE AFTER ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCER

D. Lubeck, P. Carroll, G. Grossfeld, 2001 .

Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer.

R. Cote, D. Esrig, J. Freeman, 1995, The Journal of urology.

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.

D. Lubeck, P. Carroll, E. Small, 2001, Urology.

Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.

P. Carroll, E. Small, G. Grossfeld, 1998, Urology.

Overview consensus statement.

P. Carroll, W. Fair, D. Peehl, 2001, Urology.

Technique of radical cystectomy and simultaneous repair of an abdominal aortic aneurysm.

D. Esrig, J. Freeman, J. Stein, 1996, Urology.

Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder.

P. Carroll, K. Chew, F. Waldman, 1999, Advances in experimental medicine and biology.

Original Articles LOCALLY RECURRENT PROSTATE TUMORS FOLLOWING EITHER RADIATION THERAPY OR RADICAL PROSTATECTOMY HAVE IMMUNOREACTMTY CHANGES IN KI-67 LABELING INDEX, P53 AND BCL-2

P. Carroll, K. Chew, F. Waldman, 1998 .

Clinical Manual of Urology, 3rd ed.

G. Grossfeld, 2002 .

Prospect i ve Tria l o f the Herbal Supplement PC-SPES in Pat ients With Progress ive Prostate Cancer

K. Shinohara, E. Small, R. Bok, 2000 .

Prospective T rial o f t he H erbal S upplement P C-SPES i n Patients W ith P rogressive P rostate C ancer

K. Shinohara, E. Small, R. Bok, 2000 .

Long-term side effects of treatment for testis cancer.

E. Small, G. Grossfeld, 1998, The Urologic clinics of North America.

Stromal Influences in Prostatic Carcinogenesis

S. Hayward, T. Tlsty, G. Grossfeld, 2001 .

Quantitation of apoptotic activity following castration in human prostatic tissue in vivo

P. Carroll, A. Olshen, Yuzhuo Wang, 2003, The Prostate.

Extramammary Paget's disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy.

R. Santucci, G. Grossfeld, S. Park, 2001, The Journal of urology.

Traumatic pyeloduodenal fistula: a case report and review of the literature.

J. Stein, D. Skinner, G. Grossfeld, 1996, Urology.

The nonrefluxing ileal conduit: a new form of urinary diversion.

C. Bennett, G. Grossfeld, J. Bennett, 1995, The Journal of urology.

Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy.

P. Carroll, G. Grossfeld, D. Sudilovsky, 2002, Urology.

Evaluation of asymptomatic microscopic hematuria.

P. Carroll, G. Grossfeld, G D Grossfeld, 1998, The Urologic clinics of North America.

Prognostic markers in bladder cancer: a contemporary review of the literature.

R. Cote, D. Esrig, J. Freeman, 1998, The Journal of urology.

Tumors of the Scrotum

H. Hricak, G. Grossfeld, A. Hari, 2002 .

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.

S. Groshen, R. Cote, S. Groshen, 1998, Journal of the National Cancer Institute.

Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275

M. Galsky, P. Sharma, P. Szabo, 2020, Clinical Cancer Research.

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.

J. Eastham, E. Small, G. Grossfeld, 2003, Urology.

Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.

D. Lubeck, P. Carroll, J. Moul, 2001, The Journal of urology.

Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.

D. Lubeck, P. Carroll, J. Broering, 2001, The Journal of urology.

Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.

P. Carroll, J. Broering, J. Henning, 2000, The Journal of urology.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

D. Lubeck, S. Mehta, P. Carroll, 2003, The Journal of urology.

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.

K. Shinohara, E. Small, R. Bok, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

K Stoeber, M. Meng, P. Carroll, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

S. Groshen, R. Cote, B. Bochner, 1997, Journal of the National Cancer Institute.

The role of stroma in prostatic carcinogenesis

S. Hayward, T. Tlsty, G. Grossfeld, 1998 .

Bilateral emphysematous pyelonephritis: a case report and review of the literature.

D. Esrig, D. Elmajian, J. Freeman, 1996, Urology.

Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy.

M. Meng, K. Shinohara, G. Grossfeld, 2003, Urologic oncology.

Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

D. Lubeck, S. Mehta, P. Carroll, 2002, The Journal of urology.

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.

A. D'Amico, P. Kantoff, D. Lubeck, 2002, Urology.

The use of orthotopic neobladders in women undergoing cystectomy for pelvic malignancy

G. Bartsch, S. Boyd, D. Esrig, 2004, World Journal of Urology.

Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients.

R. Cote, S. Boyd, D. Esrig, 1997, The Journal of urology.

Lower urinary tract reconstruction in the female using the Kock ileal reservoir with bilateral ureteroileal urethrostomy: update of continence results and fluorourodynamic findings.

C. Bennett, S. Boyd, J. Stein, 1996, Urology.

How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.

James M Henning, D. Lubeck, P. Carroll, 2002, The Journal of urology.

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.

P. Carroll, J. Wolf, M. Litwin, 2001, Urology.

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.

P. Carroll, H. Hricak, J. Wolf, 2001, Urology.

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.

M. Meng, P. Carroll, S. Groshen, 2002, Urology.

Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue.

R. Cote, D. Skinner, C. Taylor, 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

M. Galsky, P. Sharma, E. Kikuchi, 2019, International Journal of Clinical Oncology.

Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate.

Z. Petrovich, S. Groshen, D. Esrig, 1994, Urology.

Management of a positive surgical margin after radical prostatectomy: decision analysis.

P. Carroll, V. Weinberg, M. Roach, 2000, The Journal of urology.

Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.

P. Carroll, S. Flanders, D. Miller, 2000, Urology.

Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.

M. Meng, S. Porten, G. Grossfeld, 2020, The Urologic clinics of North America.

Simultaneous laparoscopic management of 3 urological malignancies.

M. Meng, M. Stoller, G. Grossfeld, 2002, The Journal of urology.

Transrectal Ultrasound-Guided Prostate Biopsy

P. Carroll, K. Shinohara, T. Downs, 2003 .

Renal carcinoma after laparoscopic cyst decortication.

M. Meng, M. Stoller, G. Grossfeld, 2002, The Journal of urology.

Horseshoe kidney with a retrocaval ureter.

J. Stein, D. Skinner, G. Grossfeld, 1997, Urology.

Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy.

P. Carroll, G. Grossfeld, Yu-ping Li, 2003, Urology.

Radical Retropubic Prostatectomy: The USC Experience

Z. Petrovich, J. Freeman, D. Skinner, 1996 .

Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging.

F. Coakley, G. Grossfeld, 2000, Radiologic clinics of North America.

Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.

D. Lubeck, M. Meng, P. Carroll, 2002, The Journal of urology.

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.

D. Lubeck, M. Meng, S. Mehta, 2002, Urology.

Emerging Immunotherapy Options for BCG-unresponsive Non-muscle-invasive Bladder Cancer.

M. Meng, P. Black, H. Mostafid, 2019, The Journal of urology.

Prostate cancer early detection: a clinical perspective.

P. Carroll, G. Grossfeld, G D Grossfeld, 2001, Epidemiologic reviews.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

D. Lubeck, P. Carroll, J. Broering, 2000, The Journal of urology.

A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.

M. Meng, Sam S. Chang, J. Gschwend, 2019, Journal of Clinical Oncology.

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns.

P. Carroll, V. Weinberg, M. Roach, 1999, Urology.

Abstract CT178: Nivolumab monotherapy in patients with advanced platinum-resistant urothelial carcinoma: Efficacy and safety update and association between biomarkers and overall survival in CheckMate 275

E. Plimack, M. Galsky, P. Sharma, 2018, Clinical Trials.

Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy.

P. Carroll, K. Shinohara, M. Roach, 1998, The Journal of urology.

Orthotopic urinary diversion with the ileal neobladder.

P. Carroll, G. Grossfeld, 2001, Techniques in urology.

A phase 2, randomized study of nivolumab or nivolumab plus BMS-986205 with or without intravesical bacillus Calmette-Guerin in patients with bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer: CheckMate 9UT

M. Meng, Sam S. Chang, J. Witjes, 2019, European Urology Supplements.

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

M. Cooperberg, D. Lubeck, S. Mehta, 2003, Urology.

Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.

P. Carroll, J. Henning, S. Flanders, 1998, The Journal of urology.

Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?

P. Carroll, V. Weinberg, T. Koppie, 2001, The Journal of urology.

D. Lubeck, P. Carroll, D. Penson, 2001, The Journal of urology.

Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

M. Cooperberg, D. Lubeck, S. Mehta, 2002, The Journal of urology.

Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate.

H. Sandler, P. McLaughlin, M. Roach, 2003, Urology.

Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database.

P. Carroll, J. Henning, S. Flanders, 1998, The Journal of urology.

The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.

P. Carroll, K. Shinohara, T. Koppie, 1999, The Journal of urology.

D. Lubeck, S. Mehta, P. Carroll, 2003, The Journal of urology.

The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.

D. Lubeck, P. Carroll, G. Grossfeld, 2001, Urology.

Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.

D. Lubeck, S. Mehta, P. Carroll, 2002, The Journal of urology.

Malignant transformation in a nontumorigenic human prostatic epithelial cell line.

S. Hayward, Mei Cao, G. Grossfeld, 2001, Cancer research.

Right intrathoracic renal ectopia: a case report and review of the literature.

D. Esrig, J. Freeman, J. Stein, 1999, Techniques in urology.

Title How potent is potent ? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer : Data from CaPSURE Permalink

M. Cooperberg, D. Lubeck, S. Mehta, 2003 .

Transrectal Ultrasound-Guided Prostate Biopsy

P. Carroll, K. Shinohara, T. Downs, 2003 .

Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

T. Tlsty, G. Grossfeld, A. Olumi, 2022 .

Genetic and epigenetic influences in prostatic carcinogenesis (review).

S. Hayward, T. Tlsty, G. Grossfeld, 1998, International journal of oncology.